ABSTRACT
Background: Objective of the study was toevaluate the patternsof dyslipidaemia in newly diagnosed type 2 diabetes mellitus-2 (T2DM) patients and to understand the initial management options utilised by the treating physician.Methods: The real world, retrospective, observational REcent trends in the patterns of dyslipidemia and Management strategy in newly diAgnosed Patients of type 2 diabetes mellitus-2 (REMAP-2) study was conducted at various centers including hospitals, clinics, and health care institutes across India between Apr-2021 and Mar-2022. Clinicians at the respective center captured the data in REMAP-2 study data capture form. Dyslipidemia was considered as: total cholesterol >200 mg/dl, low density lipoprotein cholesterol (LDL-C) >100 mg/dl, high density lipoprotein cholesterol (HDL-C) <40 mg/dl, or triglyceride >150 mg/dl.Results:Of 9605 newly diagnosed T2DM patients with dyslipidemia, 68.94% (n=6622) had mixed dyslipidemia. The mean age was 53.8 years. Majority of the patients were males (63.3%), had family history of diabetes (52.5%), physical activity category of 憂ot very active� or 憀ightly active� (79.33%), and were overweight or obese (58.9%). About 25.9% of the patients were smokers. Hypertension (72.33%) was the most common comorbidity followed by coronary artery disease (23.44%). The mean glycated hemoglobin (HbA1c) was 8.3%. The most commonly prescribed antidiabetic medication was metformin (87.71%), while lipid lowering therapy was atorvastatin (77.79%).Conclusions:This study on newly diagnosed T2DM patients with dyslipidemia found that majority of the patients had hypertriglyceridemia, family history of diabetes and were physically inactive. More than half of T2DM patients were either overweight or obese. More than2/3rdof the patients had mixed dyslipidemia. Statins were prescribed to the majority of these patients and atorvastatin was the most commonly prescribed statin in Indian T2DM patients with dyslipidemia.
ABSTRACT
Background: Neonatal sepsis is one of the major causes of death and morbidity among neonates in India; however, studies related to neonatal sepsis are somewhat in limited numbers. Furthermore, time to time sensitivity and efficacy of various antimicrobial agents (AMA) change which necessitates studies related to antimicrobial drug utilization in hospitals. The objective of present study was to evaluate the pattern of use of AMAs in neonatal sepsis at the neonatal intensive care unit (NICU) at a tertiary care hospital in western part of India. Methods: It was a prospective cross-sectional study conducted over a period of 6-month duration in NICU at tertiary care hospital. Data were collected and analyzed. Results: It has been observed that 57.67% patients were pre-term, 42.32% full term; 23.28% were of normal birth weight, 58.73% low birth weight and 15.34% were very low birth weight. In 48.7% of patients, two different antibiotics were prescribed while in 40.1% of patients three different antibiotics were prescribed. A total number of antibiotics prescribed were 499, per patient 2.78 antibiotics were prescribed. Amikacin was used in 73.01% cases while cefotaxime was used in 64.55% of cases. Piperacilin + tazobactam combination was used in 41.26% cases. In 50.9% cases, antibiotics were prescribed by generic name. Conclusion: Antibiotic resistance is increasing due to the irrational prescribing habits of physicians, leading to increasing morbidity, mortality and treatment costs. Therefore, the medical professionals as well as government personnel who are related to the health sector need to understand that antibiotics are precious and finite resources. The remedy of this situation requires that regular educational awareness programs should be conducted in hospitals at a regular basis.